Rojas-Osornio, S.A.; Crespo-RamÃrez, M.; Paredes-Cervantes, V.; Mata-MarÃn, A.; MartÃnez-Lara, R.; Pérez de la Mora, M.; Tesoro-Cruz, E.
Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice. Pharmaceuticals 2024, 17, 801.
https://doi.org/10.3390/ph17060801
AMA Style
Rojas-Osornio SA, Crespo-RamÃrez M, Paredes-Cervantes V, Mata-MarÃn A, MartÃnez-Lara R, Pérez de la Mora M, Tesoro-Cruz E.
Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice. Pharmaceuticals. 2024; 17(6):801.
https://doi.org/10.3390/ph17060801
Chicago/Turabian Style
Rojas-Osornio, Sandra Angélica, Minerva Crespo-RamÃrez, Vladimir Paredes-Cervantes, Antonio Mata-MarÃn, Ricardo MartÃnez-Lara, Miguel Pérez de la Mora, and Emiliano Tesoro-Cruz.
2024. "Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice" Pharmaceuticals 17, no. 6: 801.
https://doi.org/10.3390/ph17060801
APA Style
Rojas-Osornio, S. A., Crespo-RamÃrez, M., Paredes-Cervantes, V., Mata-MarÃn, A., MartÃnez-Lara, R., Pérez de la Mora, M., & Tesoro-Cruz, E.
(2024). Oral Administration of Efavirenz Dysregulates the Tph2 Gene in Brain Serotonergic Areas and Alters Weight and Mood in Mice. Pharmaceuticals, 17(6), 801.
https://doi.org/10.3390/ph17060801